Physician profile
Daniel S Ong
NPI 1427292705
$6,619.45
in general payments reported to CMS, 2019-2025
39 companies · $1,142 in 2025
The $1,142 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $879 · 2020: $622 · 2021: $714 · 2022: $943 · 2023: $1,172 · 2024: $1,148 · 2025: $1,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,461.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $763.54 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $734.64 | 2021-2025 | Verquvo |
| Amgen INC. | $688.73 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $661.31 | 2019-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $538.74 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $509.35 | 2019-2025 | |
| Boston Scientific Corporation | $343.61 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, General - Therapies, General - Brady |
| Biotronik INC. | $231.19 | 2023-2025 | Amvia Edge, Rivacor 7 Dr-T, Edora 8 Dr-T |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.93 | 2020-2025 | Jardiance |
| Pfizer INC. | $213.77 | 2022-2025 | |
| Abbott Laboratories | $196.91 | 2020-2025 | Mitraclip, Jot Dx |
| Amarin Pharma, INC. | $176.30 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $168.69 | 2019-2024 | Xarelto |
| Medtronic, INC. | $131.40 | 2021-2024 | Onyx Frontier |
| Abiomed | $106.64 | 2021-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.